US4602909A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Iontophoresis intermediary material and contact solution for the treatment of chronic pain syndromes
Assignee: Richter Gedeon Vegyeszeti Gyar Nyrt
•
Filing: 1983-02-07
•
Granted: 1986-07-29
•
Expires: 2003-02-07
Abstract
Abstract A method of treating chronic pain is disclosed which comprises the step of topically administering to the skin of a human patient, 1 to 100 mu g/cm2 of body surface of a compound of the Formula (I) <IMAGE> (I) in which R is -CH3 or -CHO R1 is methoxy or amino; R2 is hydrogen, hydroxyl or acetoxy; R3 is hydrogen or ethyl; R4 and R5 together form a valency bond or an epoxy bridge, or R4 is hydroxy or ethyl; and R5 is hydrogen; or a pharmaceutically acceptable acid addition salt thereof, by iontophoresis.
Inventors
- 👤 Bertalan Csillik
- 👤 Erzsebet Knyihar
- 👤 Attila Szucs
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 04:36
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/475; A61K9/00; A61K9/0002; A61K9/0009; A61P; A61P25/00; A61P25/02
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
103 words
A method of treating a chronic pain syndrome in a human, which comprises the step of topically administering to the skin of the human 1 to 100 μg/cm 2 of body surface of a compound of the Formula (I) ##STR3## in which R is --CH 3 or --CHO; R 1 is methoxy or amino; R 2 is hydrogen, hydroxyl or acetoxy; R 3 is hydrogen or ethyl; R 4 and R 5 together form a valency bond or an epoxy bridge, or R 4 is hydroxyl or ethyl; and R 5 is hydrogen; or a pharmaceutically acceptable acid addition salt thereof, by iontophoresis.
Claim 2
Independent Claim
103 words
A method of treating a chronic pain syndrome in a human, which comprises the step of topically administering to the skin of the human 1 to 100 μg/cm 2 of body surface of a compound of the Formula (I) ##STR3## in which R is --CH 3 or --CHO; R 1 is methoxy or amino; R 2 is hydrogen, hydroxyl or acetoxy; R 3 is hydrogen or ethyl; R 4 and R 5 together form a valency bond or an epoxy bridge, or R 4 is hydroxyl or ethyl; and R 5 is hydrogen; or a pharmaceutically acceptable acid addition salt thereof, by iontophoresis.
Claim 3
Dependent Claim
30 words
The method of treating a chronic pain syndrome defined in claim 1 wherein the compound of the Formula (I) is vinblastine in the form of its sulfate acid addition salt.
Claim 4
Dependent Claim
30 words
The method of treating a chronic pain syndrome defined in claim 1 wherein the compound of the Formula (I) is vincristine in the form of its sulfate acid addition salt.
Claim 5
Dependent Claim
20 words
The method of treating a chronic pain syndrome defined in claim 1 wherein the chronic pain syndrome is postherpetic neuralgia.
References Cited (Backward Citations)
US1967927A
Cited
US3163166A
Cited
US3677268A
Cited
US3749784A
Cited
GB1548621A
Cited
US4141359A
Cited
GB1596235A
Cited
GB1603384A
Cited
GB2012260A
Cited
GB2116037A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-07-28 | 1990-01-27 | 1990-07-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-07-28 | 1994-01-27 | 1994-07-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-07-28 | 1998-01-27 | 1998-07-29 | $7700.00 | Window Closed / Lapsed |